EVG.L Regulatory News (EVG)

EVG.L Information

There is currently no data for EVG

REMOVE ADS

Merger Update

25 Nov 2011 12:00

RNS Number : 7932S

Office of Fair Trading

25 November 2011

Merger clearance

The OFT has decided, on the information currently available to it, not to refer the following merger to the Competition Commission under the provisions of the Enterprise Act 2002:

Anticipated acquisition by Investec plc of Evolution Group plc

The text of this decision will be placed on the Office of Fair Trading's website at www.oft.gov.uk as soon as is reasonably practicable.

In the event of media enquiries, please call the OFT Press Office on 020 7211 8899.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MERFEMFFIFFSESF

Date		Source	Headline
28th Mar 2019	7:00 am	RNS	Poster presentation of Imperial College data
25th Mar 2019	7:00 am	RNS	SFX-01 meets primary endpoints in STEM trial
18th Mar 2019	2:01 pm	RNS	Price Monitoring Extension
18th Mar 2019	7:00 am	RNS	Update on SFX-01 trial read-out dates
5th Mar 2019	7:00 am	RNS	SFX-01 data published in peer reviewed journal
6th Feb 2019	3:30 pm	RNS	Holding(s) in Company
5th Feb 2019	7:00 am	RNS	Clinical trial update confirms read-outs on track
30th Jan 2019	5:28 pm	RNS	Grant of Options
23rd Jan 2019	7:00 am	RNS	SFX-01 featured in Nature Reviews Drug Discovery
22nd Jan 2019	7:00 am	RNS	Change of Adviser
19th Dec 2018	6:02 pm	RNS	Share option exercise and issue of equity
12th Dec 2018	7:00 am	RNS	Interim Results
10th Dec 2018	3:00 pm	RNS	Nominated Adviser Status
4th Dec 2018	7:00 am	RNS	Poster Presentation of SFX-01 and Trial Update
3rd Dec 2018	7:00 am	RNS	Notification of Half Year Results
19th Nov 2018	7:00 am	RNS	Investor Presentation in Manchester
8th Nov 2018	7:00 am	RNS	Directorate Changes
23rd Oct 2018	9:57 am	RNS	Holding(s) in Company
18th Oct 2018	7:00 am	RNS	Placing
18th Sep 2018	7:00 am	RNS	Investor Symposium
11th Sep 2018	7:00 am	RNS	Notice of Investor Symposium
26th Jul 2018	3:22 pm	RNS	Result of AGM
26th Jul 2018	7:00 am	RNS	AGM Statement
25th Jul 2018	7:00 am	RNS	Final Patient Recruited in STEM Phase IIa Trial
10th Jul 2018	11:00 am	RNS	Grant of share options, issue of equity and TVR
29th Jun 2018	10:45 am	EQS	Hardman & Co Research: Evgen Pharma (EVG): 2018, a pivotal year
21st Jun 2018	12:30 pm	RNS	Posting of Annual Report and AGM Notice
13th Jun 2018	2:15 pm	EQS	Hardman & Co Research: Evgen Pharma (EVG): Encouraging interim data from the STEM trial
13th Jun 2018	7:00 am	RNS	Full Year Results
11th Jun 2018	9:05 am	RNS	Second Price Monitoring Extn
11th Jun 2018	9:00 am	RNS	Price Monitoring Extension
11th Jun 2018	7:00 am	RNS	Interim Update on STEM Trial
7th Jun 2018	4:40 pm	RNS	Second Price Monitoring Extn
7th Jun 2018	4:35 pm	RNS	Price Monitoring Extension
30th May 2018	7:00 am	RNS	Notification of Preliminary Results
15th May 2018	11:00 am	RNS	Price Monitoring Extension
14th May 2018	7:00 am	RNS	Upcoming Investor Presentations
2nd May 2018	7:00 am	RNS	Grant of further European patent
26th Apr 2018	4:40 pm	RNS	Second Price Monitoring Extn
26th Apr 2018	4:35 pm	RNS	Price Monitoring Extension
24th Apr 2018	7:00 am	RNS	Presentation at World Orphan Drug Congress USA
20th Mar 2018	7:00 am	RNS	Research Collaboration with Imperial College
5th Mar 2018	7:00 am	RNS	Update on Novel Sulforaphane Analogues
15th Jan 2018	7:00 am	RNS	Poster Presentation of SFX-01 Mechanistic Data
10th Jan 2018	4:31 pm	RNS	Notification of Major Interest in Shares
5th Jan 2018	9:49 am	RNS	Notification of Major Interest in Shares
5th Jan 2018	9:48 am	RNS	Notification of Major Interest in Shares
2nd Jan 2018	5:44 pm	RNS	Total Voting Rights
28th Dec 2017	11:49 am	RNS	Result of General Meeting
22nd Dec 2017	10:10 am	RNS	Grant of Options

Latest Share Chat

EVG.L Regulatory News (EVG)

Merger Update

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending